Kok-Onn Lee

Kok-Onn Lee

Auto-generated profile, based on publicly available information

Kok-Onn Lee

Department of Medicine, National University of Singapore, Singapore

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
JCJens Sandahl Christiansen
Jens Sandahl Christiansen
PBPhilippe F Backeljauw
Philippe F Backeljauw
MBMartin Bidlingmaier
Martin Bidlingmaier
BBBeverly M K Biller
Beverly M K Biller
MBMargaret C S Boguszewski
Margaret C S Boguszewski
KYKevin Yuen
Kevin Yuen
Objective: The Growth Hormone (GH) Research Society (GRS) convened a workshop to address important issues regarding trial design, efficacy, and safety of long-acting growth hormone preparations (LAGH). Participants: A closed meeting of 55 international scientists with expertise in GH, including pediatric and adult endocrinologists, basic scientists, regulatory scientists, and participants from the pharmaceutical industry. Evidence: Current literature was reviewed for gaps in knowledge. Expert opinion was used to suggest studies required to address potential safety and efficacy issues. Consensus process: Following plenary presentations summarizing the literature, breakout groups discussed questions framed by the planning committee. Attendees reconvened after each breakout session to share group reports. A writing team compiled the breakout session reports into a draft document that was discussed and revised in an open forum on the concluding day. This was edited further and then circulated to attendees from academic institutions for review after the meeting. Participants from pharmaceutical companies did not participate in the planning, writing, or in the discussions and text revision on the final day of the workshop. Scientists from industry and regulatory agencies reviewed the manuscript to identify any factual errors. Conclusions: LAGH compounds may represent an advance over daily GH injections because of increased convenience and differing phamacodynamic properties, providing the potential for improved adherence and outcomes. Better methods to assess adherence must be developed and validated. Long-term surveillance registries that include assessment of efficacy, cost-benefit, disease burden, quality of life, and safety are essential for understanding the impact of sustained exposure to LAGH preparations.

7 September 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SMSvetlana Mukhina
Svetlana Mukhina
HMHichem C. Mertani
Hichem C. Mertani
KGKe Guo
Ke Guo
KLKok-Onn Lee
Kok-Onn Lee
PGPeter D. Gluckman
Peter D. Gluckman
PLPeter E. Lobie
Peter E. Lobie
We report here that autocrine production of human growth hormone (hGH) results in a phenotypic conversion of mammary carcinoma cells such that they exhibit the morphological and molecular characteristics of a mesenchymal cell, including expression of fibronectin and vimentin. Autocrine production of hGH resulted in reduced plakoglobin expression and relocalization of E-cadherin to the cytoplasm, leading to dissolution of cell-cell contacts and decreased cell height. These phenotypic changes were accompanied by an increase in cell motility, elevated activity of specific matrix metalloproteinases, and an acquired ability to invade a reconstituted basement membrane. Forced expression of plakoglobin significantly decreased mammary carcinoma cell migration and invasion stimulated by autocrine hGH. In vivo , autocrine hGH stimulated local invasion of mammary carcinoma cells concomitant with a prominent stromal reaction in comparison with well delineated and capsulated growth of mammary carcinoma cells lacking autocrine production of hGH. Thus, autocrine production of hGH by mammary carcinoma cells is sufficient for generation of an invasive phenotype. Therapeutic targeting of autocrine hGH may provide a mechanistic approach to prevent metastatic extension of human mammary carcinoma.

1 February 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XZXin Zhang
Xin Zhang
TZTao Zhu
Tao Zhu
YCYong Chen
Yong Chen
HMHichem C. Mertani
Hichem C. Mertani
KLKok-Onn Lee
Kok-Onn Lee
PLPeter E. Lobie
Peter E. Lobie
Increased mammary epithelial expression of the human growth hormone (hGH) gene is associated with the acquisition of pathological proliferation. We report here that autocrine hGH production by human mammary carcinoma cells increased the expression and transcriptional activity of the homeobox domain containing protein HOXA1. Forced expression of HOXA1 in human mammary carcinoma cells resulted in increased total cell number primarily by the promotion of cell survival mediated by the transcriptional up-regulation of Bcl-2. HOXA1 also abrogated the apoptotic response of mammary carcinoma cells to doxorubicin. Forced expression of HOXA1 in mammary carcinoma cells, in a Bcl-2-dependent manner, resulted in dramatic enhancement of anchorage-independent proliferation and colony formation in soft agar. Finally, forced expression of HOXA1 was sufficient to result in the oncogenic transformation of immortalized human mammary epithelial cells with aggressive in vivo tumor formation. Herein, we have therefore provided a molecular mechanism by which autocrine hGH stimulation of human mammary epithelial cells may result in oncogenic transformation.

1 January 2005 in Cancer Research
Verified
Journal Article
Open access
PDF file
TZTao Zhu
Tao Zhu
SBStarling Emerald Bright
Starling Emerald Bright
XZXin Zhang
Xin Zhang
KLKok-Onn Lee
Kok-Onn Lee
PGPeter D. Gluckman
Peter D. Gluckman
PLPeter E. Lobie
Peter E. Lobie
The human growth hormone (hGH) gene is expressed in the normal human mammary epithelial cell and its expression increases concomitant with the acquisition of proliferative lesions. Herein we demonstrate that autocrine production of hGH in human mammary carcinoma cells dramatically enhances anchorage-independent growth in a Janus kinase 2–dependent manner. Forced expression of the hGH gene in immortalized human mammary epithelial cells increased proliferation, decreased apoptosis, altered the cellular morphology and resulted in oncogenic transformation. Autocrine hGH was therefore sufficient to support anchorage-independent growth of immortalized human mammary epithelial cells and tumor formation in vivo. Moreover, autocrine hGH disrupted normal mammary acinar architecture with luminal filling and deregulated proliferation in three-dimensional epithelial cell culture. Autocrine hGH utilized homeobox A1 to govern the transcriptional program required for autocrine hGH–stimulated oncogenic transformation of human mammary epithelial cells, including transcriptional up-regulation of c-Myc, cyclin D1, and Bcl-2. Forced expression of a single orthotopically expressed wild-type gene is therefore sufficient for oncogenic transformation of the immortalized human mammary epithelial cell.

1 June 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Kai Soo TanKai Soo Tan
Kai Soo Tan
KLKok Onn Lee
Kok Onn Lee
KLKee Chung Low
Kee Chung Low
AGAkshamal Mihiranga Gamage
Akshamal Mihiranga Gamage
YLYichun Liu
Yichun Liu
YGYunn-Hwen Gan
Yunn-Hwen Gan
Individuals with type 2 diabetes are at increased risk of acquiring melioidosis, a disease caused by Burkholderia pseudomallei infection. Although up to half of melioidosis patients have underlying diabetes, the mechanisms involved in this increased susceptibility are unknown. We found that B. pseudomallei–infected PBMCs from diabetic patients were impaired in IL-12p70 production, which resulted in decreased IFN-γ induction and poor bacterial killing. The defect was specific to the IL-12–IFN-γ axis. Defective IL-12 production was also observed during Mycobacterium tuberculosis infection, in which diabetes is likewise known to be a strong risk factor. In contrast, IL-12 production in diabetic cells was not affected upon Salmonella enterica infection or in response to TLR2, -3, -4, and -5 ligands. Poor IL-12 production correlated with a deficiency in intracellular reduced glutathione (GSH) concentrations in diabetic patients. Addition of GSH or N-acetylcysteine to PBMCs selectively restored IL-12 and IFN-γ production and improved bacterial killing. Furthermore, the depletion of GSH in mice led to increased susceptibility to melioidosis, reduced production of IL-12p70, and poorer disease outcome. Our data thus establish a link between GSH deficiency in diabetes and increased susceptibility to melioidosis that may open up new therapeutic avenues to protect diabetic patients against some intracellular bacterial pathogens.

1 July 1999 in Experimental Cell Research
Verified
Journal Article
Closed access
KKKarmaljeet K. Kaulsay
Karmaljeet K. Kaulsay
HMHichem C. Mertani
Hichem C. Mertani
JTJan Törnell
Jan Törnell
GMGérard Morel
Gérard Morel
KLKok-Onn Lee
Kok-Onn Lee
PLPeter E. Lobie
Peter E. Lobie